Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q2 2023 Earnings Call Transcript August 9, 2023
Adaptimmune Therapeutics plc misses on earnings expectations. Reported EPS is $-0.21 EPS, expectations were $-0.17.
Operator: Good morning, ladies and gentlemen and welcome to Adaptimmune’s Q2 Financial and Business Update Conference Call. I would now like to turn the meeting call over to Ms. Juli Miller. Please go ahead, Ms. Miller.
Juli Miller: Good morning, and welcome to Adaptimmune’s...
